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Introduction
Psoriasis is defined as an immune-mediated multiple-cause dis-
ease of  genetic basis [1] and different phenotypes [2] that affects 
up to 8.5% of  the population in the Western countries and re-
quires careful management [3]. Among the skin chronic forms of  
psoriasis, those with circumscribed thick white to silver plaques, 
surrounded by areas redness are more common [4]. Psoriasis can 
spread to the elbows, knees, shins, scalp, lower back, nails, geni-
tals, mouth and joint areas with many grades of  damage, lead-
ing to the emotional consequences with negative impact in the 
patient’s life [3, 6]. Oral cavity can reveals details about systemic 
health status. Oral diseases also have immune-involvement with 
multiple causes and can lead to local and systemic complications. 
Oral care are the health treatments that people more often have 
performed [74]. Relying on surgical resources and increasingly ad-
vanced pharmacological therapy, these treatments can lead to the 
damages, even in healthy patients [4]. In some conditions, dental 
treatments can be invasive and for Psoriasis it can cause problems 
in complex ways. The oral aspects for psoriasis were not assessed 
with a comprehensive literature review and accurate inferences 
are possible only if  a previous systematic analysis of  risk factors 
was done [5].
Methods
In order to map the knowledge, according the Health Based Evi-
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Abstract
Background: Psoriasis and oral health are overlap in different ways, sometimes with complex and uncertain outcomes. 
Objective: It is to map the knowledge about the oral health status issues for psoriasis. 
Methods: We conducted qualitative systematic review of  clinical trials literature. 
Results: There are different issues about oral health status related to the observed outcomes. It was recovered 830 studies, 11 
were able to fill partially the inclusion criteria for this review with 293.231 participants. The highest level of  evidence obtained 
was 2 A (Randomized Clinical Trial), for the oral psoriasis arthritis forms at TMJ issue with one study. About the periodontal 
diseases issue was obtained the second highest level of  evidence 2B (Clinical Trial Case-Control), with 10 studies. 
Limitations: The main limitation was the lack of  inclusion of  unpublished studies. 
Conclusions: For clinicians It is important consider oral implications for all psoriasis patients. Among possible issues, it is 
relevant to state that the conventional treatments for psoriasis are able to produce oral adverse events [75]. Periodontal dis-
eases, seems to be related to the severity of  psoriasis, because the level of  evidence was only 2B, although its intrinsic mecha-
nisms are not known. Further studies are required to state a minimum dental care protocol. In general, for better outcomes 
in Psoriasis, professional must adopt an assessment risk scales, such as the “physical status classification system” from the 
American Society of  Anesthesiologists (ASA) and observe statements, such those the American Dental Association, prior to 
any interventions, concerning to the degree of  coverage and invasiveness of  each dental procedure and the risk of  adverse 
events before, during and after the consultation for these patients.
 Keywords: Dental Care for Chronically Disease; Drug Utilization; Psoriasis; Morbidity; Risk Factors.
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dence criteria, a P.I.C.O.T. question was made, “Which are the oral 
issues for psoriasis? It was observed different issues concerning 
the theme:
1. Issues related to the pathogenesis of  Psoriasis
1.1. Oral findings in psoriasis. 
1.2. Oral psoriasis arthritis at temporomandibular joint (TMJ). 
2. Issues related to the clinical implications due Psoriasis
2.1. Periodontal diseases related to the psoriasis.
2.2. Conventional treatments and oral outcomes.
 2.2.1. Inducing oral adverse outcomes.
 2.2.2. Worsening oral adverse outcomes.
 2.2.3. Inducing oral favorable outcomes.
2.3. Conventional treatments for diseases related to psoriasis in-
ducing oral adverse events.
 2.3.1. For Prior Morbidities related to psoriasis.
 2.3.2. For Co Morbidities related to psoriasis.
 2.3.3. For Post Morbidities related to psoriasis.
2.4. Dental treatments and psoriasis:
 2.4.1.Inducing systemic favorable outcomes to psoriasis. 
 2.4.2.Triggering systemic psoriasis.
 2.4.3.Worsening psoriasis. 
2.5. Oral risk factors able to induce exacerbation to psoriasis. 
It was conducted a systematic review in accordance to the 
Cochrane Collaboration for Qualitative Research Group (CCQR; 
Bangor University, Wales, UK) [8] within the Evidence-Based 
Health Program model at the service (GEPSOS) Grupo de Es-
tudos e Pesquisas Saúde Oral e Sistêmica Baseada em Evidências, 
Ambulatório Multidisciplinar Psoríase I Departamento Derma-
tologia, Escola Paulista de Medicina Unifesp in São Paulo, Bra-
zil, and received ethics committee approval from the Ministry of  
Health of  Republic of  Brazil. Its prior protocol project was struc-
tured based on PRISMA (Preferred reporting items for systematic 
reviews and meta-analyses). For the assessment of  the risk of  bias 
of  each included study was used using the criteria described in the 
Cochrane Handbook for Systematic Reviews of  Interventions[8, 
9] according to the following domains:
1. Random sequence generation (selection bias);
2. Allocation concealment (selection bias);
3. Blinding of  participants and personnel (performance bias);
4. Blinding of  outcome assessment (detection bias);
5. Incomplete outcome data (attrition bias);
6. Selective reporting (reporting bias);
7. Other bias (other sources of  bias related to a particular trial 
design, e.g. cross-over or cluster-randomized, or specific circum-
stances, e.g. interventions mixed). 
Each of  the items is judged as low risk of  bias, high risk of  bias or 
unclear risk of  bias, for included studies [9]. (Table 2)
The assessment of  methodological quality was done according 
the Consolidated Standards of  Reporting Trials CONSORT state-
ments [7], and was applied Appendix B Criteria Used in Quality 
Assessment of  Non-Randomized Studies Scale [10]. Amstar Scale 
for systematic reviews and Higgins domains tools scale [9], were 
used for assessment of  the methodological quality and for risk of  
bias, respectively. (TABLE 3) 
The study also was submitted to the register at International Pro-
spective Register of  Systematic Reviews PROSPERO, University 
of  York/UK. The search included both randomized controlled 
trials and controlled trials that investigated dental improvement 
of  psoriasis as the primary end point without limit for either date 
of  publication or language.
We used the following databases as source up to 28 May 2015: 
Cochrane Skin Group Specialized Register; Cochrane Central 
Register of  Controlled Trials (CENTRAL) 2014, Issue 5; MED-
LINE from 1946 (via Pubmed); Embase from 1974; CINAHL 
(Cumulative Index to Nursing and Allied Health Literature) from 
1981; Salford Database of  Psoriasis trials; ISI Web of  Science; 
HealthSTAR; LILACS (Literatura Latino-Americana e do Caribe 
em Ciências da Saúde); IBECS (Índice Bibliográfico Español en 
Ciencias de la Salud) and hand search at Unifesp Library. The 
search strategy for MEDLINE can be seen in Box 1.
We aimed to identify all relevant Randomized Clinical Trials and 
other studies regardless of  language or publication status (pub-
lished, unpublished, in press, or in progress). The studies retrieved 
were assessed for eligibility by reading the title and abstract. All 
eligible studies were read in full text in the evaluation for inclu-
sion. Both the process of  assessing eligibility for the inclusion of  
studies was performed by two independent evaluators regarding 
the validity, content and disagreements were consensus resolved. 
The extraction of  data from selected studies was based on the 
standard Cochrane Collaboration data extraction forms modified 
to meet the needs of  the present review.
Results
According to PRISMA statement the flow of  information 
through the different phases of  a systematic review concerning 
the identification, screening, eligibility and inclusion of  studies 
was made [11]. (Table 1)
There are different issues about oral health status related to the 
observed outcomes. None of  included studies was able to answer 
PICO question completely. It was recovered 2085 studies, 11 were 
able to fill partially the inclusion criteria for this review despite 
293.231 participants (Table 2).
The highest level of  evidence obtained was 2 A (Randomized 
Clinical Trial), for the oral psoriatic arthritis forms at TMJ issue 
with one study. About the periodontal diseases issue was obtained 
the second highest level of  evidence 2B (Clinical Trial Case-Con-
trol), with 10 studies. The concordance rate between evaluators 
was 98% [12]. Under these circumstances, and due the practical 
relevance of  the theme, it was performed a qualitative analysis of  
included studies [10]. 
The strengths of  the present study were in the broad literature 
search, explicit methods, selection and evaluation of  duplicate 
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studies, assessment of  the methodological quality of  the included 
studies, summaries of  the findings. The retrieved studies varied 
widely in many aspects. The main limitations of  present review 
were due to the lack of  inclusion of  unpublished studies and due 
to sparse studies with poor methodological quality which did not 
allow us to make any statistical analysis, nor measure of  treatment 
effect, the impossibility to state any unit of  analysis issues, nor 
subgroup analysis and investigation of  heterogeneity either, even 
it was not available to consider the P value for each assessed study. 
Additional points; the limitations of  the review were to show how 
to avoid these limitations, or make them less likely to influence the 
results. It was not possible to establish any comparison of  results 
with the existing literature as this did not exist. However, it would 
be interesting to compare dental health studies in other systemic 
autoimmune diseases (lupus, for example) or chronic skin (viti-
ligo, for example) but also no such studies were found. In order 
to allow a comprehensive mapping of  knowledge it were stated 
issues but at practices all these different clinical conditions often 
overlap resulting in the complex observed outcomes. No study 
had high enough methodological standards to be able to permit 
the establishment a cause-effect relationship between the condi-
tions. About the issues, only one of  those had 10 studies which 
was able to fill partially the inclusion criteria for this review. The 
methodological quality and risk of  bias were assessed by APPEN-
DIX B scale and Higgins domains tools, respectively.
Discussion
Psoriasis and oral health status can influence themselves recipro-
cally with relevance for observed outcomes.
1. Issues Related to the Pathogenesis of  Psoriasis: It Means 
That Present Issues are the Oral Manifestations of  Disease
 
Box 1.
#1 “Psoriasis” [Mesh] OR “Psoriases” [Text Word] OR “Pustulosis of  Palms and Soles”[ Text Word] OR “Pustulosis 
Palmaris et Plantaris” [Text Word] OR “Palmoplantaris Pustulosis” [Text Word] OR “Pustular Psoriasis of  Palms 
and Soles” [Text Word] OR “Arthritis, Psoriatic” [Mesh] OR “Psoriatic Arthritis” [Text Word] OR “Psoriasis Ar-
thropathica” [Text Word] OR “Psoriasis, Arthritic” [Text Word] OR “Arthritic Psoriasis” [Text Word] OR “Pso-
riasis, Arthritis” [Text Word] OR “Glossitis, Benign Migratory” [Mesh] OR “Benign Migratory Glossitis” [Text 
Word] OR “Migratory Glossitis, Benign” [Text Word] OR “Tongue, Fissured” [Text Word] OR “Glossitis Areata 
Exfoliativa” [Text Word] OR “Geographic Tongue” [Text Word] OR “Stomatitis Areata Migrans” [Text Word]
#2 “Oral Health” [Mesh] OR “Dentistry” [Mesh] OR “Tongue” [Mesh] OR “Tongue, Fissured” [Mesh] OR “Fis-
sured Tongue” [Text Word] OR “Fissured Tongues” [Text Word] OR “Tongues, Fissured” [Text Word] OR 
“Lingua Plicata” [Text Word] OR “Scrotal Tongue” [Text Word] OR “Tongue, Furrowed”[Text Word] OR “Fur-
rowed Tongue” [Text Word] OR “Furrowed Tongues” [Text Word] OR “Tongues, Furrowed” [Text Word] OR 
“Tongues, Fissure” [Text Word] OR “Stomatitis” [Mesh] OR “Stomatitides” [Text Word] OR “Oral Mucositis” 
[Text Word] OR “Mucositides, Oral” [Text Word] OR “Oral Mucositides” [Text Word] OR “Oromucositis” [Text 
Word] OR “Oromucositides” [Text Word] OR “Mucositis, Oral” [Text Word]
#3 Rct OR Cct OR Random
#4 #1 AND #2 AND #3
Table 1. Prisma FLOW.
Records Identified through 
database searching 830 
records
Additional record identi-
fied through other source: 
1
Duplicates removed: 1
Records screened: 830
Full-text article assessed 
for eligibility: 13
Studies (case-controlled) 
included in qualitative 
synthesis due met partially 
the inclusion criteria for 
this review: 11
Records were excluded due 
refers literary chronicles, 
basic researches: 817
Full text article were ex-
cluded due refers 
case-reports: 2
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1.1. Oral findings in psoriasis: Although it is found different 
types of  oral lesions related to psoriasis (whitish minimum round 
or oval zones, when scraped to leave the mucous surface bloody 
[17]); (surrounded whitish plaque reddened similar to psoriasis 
skin lesions [17]); (bright red mucosal lesions). Often they are in 
pustular psoriasis forms, erythrodermic psoriasis and Reiter's syn-
drome [17] as well.
Benign migration glossitis or geographic tongue (G.T.) and sto-
matitis are at a migration [17, 36, 51, 52] (SAM), have more pub-
lished studies and are psoriasis.
(G.T.) is one the most prevalent [89, 95, 97] and is an oral lesion 
that affects adults and children [98]. It is a benign inflammatory 
disorder at the dorsum and margins of  the tongue where occurs 
the replacement the filiform papilla epithelium to irregular central 
erythematous patches surrounded by elevated whitish band-like 
border. The lesions are able to change the location, size, and pat-
tern over a period of  time, and may spontaneously exhibit periods 
of  remission and exacerbation, with generally good prognosis. 
(G.T.) sometimes causes pain and burning sensation and poor re-
sponse to ordinary remedies [90].
Often (G.T.) and (S.A.M.) are clinical findings with few under-
standing, and there is not yet consensus between authors [121], 
about many aspects of  pathogenesis, despite already is known 
that both lesions share histological similarities to psoriasis [17, 
66, 67]. Under these circumstances (G.T.) and (S.A.M) is impor-
tant to be stated these lesions are psoriasis, including, sometimes 
they can overlap with other genetic diseases and to be present 
in different clinical conditions [87, 93, 96, 123] and syndromes 
[85, 86, 88, 92, 94], where this oral psoriasis forms must to be 
faced as comorbidities [17]. In a time line, there are reports about 
(G.T. and S.A.M.) were induced by anti-cancer therapies when the 
drugs were used for the treatment of  psoriasis systemic [75, 76]. 
In other hand, there is a report about anti psoriatic therapy with 
etretinate that was observed a remarkable regression in the (G.T.) 
[75] suggesting the (G.T.) is a typical symptom of  psoriasis pustu-
losa generalisata [75].
1.2. Oral psoriasis arthritis forms at temporomandibular 
joint: Reports about the existence of  manifestation of  psoriasis 
arthritis in the temporomandibular joint (TMJ) including imaging 
features, and TMJ anquilosis for both gender, in different ethnics, 
and ages [54, 55, 99-111]. 
 
A cross-sectional survey randomly selected sample of  690 elderly 
people in Africa to assess oral mucosal lesions and temporoman-
dibular joint impairment, and (22.46%) had one or more oral 
pathology lesions, representing infection-related swelling, non-
infection-related swelling, pre-malignant lesions, denture stomati-
tis, non denture based ulcers, angular cheilitis, geographic tongue, 
scrotal tongue, lichen planus, hyper-pigmentation and TMJ im-
pairment [101]. There are reports about well successful surgical 
approaches for the TMJ disorders in the psoriatic arthritis [103], 
Although one recovered study stated to be randomized, for the 
issue psoriasis at TMJ, it was not possible assess completely the 
criteria high level of  biases. 
2. Issues related to the clinical implications due the psoria-
sis:
It means when the disease are able to induce oral manifestations 
and oral health status are able to lead psoriasis at different out-
comes.
2.1. Periodontal diseases related to the psoriasis: No study 
was able to state which disease came first. The scope of  present 
study was to assess the possibility that the periodontal disease can 
to contribute to inducing or worsening psoriasis lesions [126]. 
Table 2. APPENDIX B. Criteria Used in Quality Assessment of  Non-Randomized Studies.
Study Participants
Outcomes
assessed and
reported
Measurement
same for all
subjects
Confounding
controlled Interventions
Preus 2010 155 Psoriasis / 155 Control Yes Yes No Yes
Keller 2012 115 365 Psoriasis /115 365 Control Yes Yes No Yes
Lazidouou 2013 100 Psoriasis /100 Control Yes Yes No Yes
Nakib S et al., 2013 60,457 women Yes Yes Yes Yes
Antal M et al., 2014 82 psoriasis patients and 89 controls Yes Yes Yes No
Sharma et al., 2015 33 psoriasis patients and 35 healthy controls Yes Yes Yes Yes
Fadel 2013 85 Psoriasis /54 Control Yes Yes No Yes
Rahul et al., 2011 100 patients, 50 with CP and 50 with psoriasis Yes Yes Yes Yes
Üstün 2013 51 Psoriasis / 51 Control Yes Yes No Yes
Skudutyte-Rysstad 
2014
50 Psoriasis/
121 Control Yes Yes No Yes
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The global prevalence of  dental diseases is high. Some between 
4% to 12% adults in U.S.A. are affected with advanced periodon-
titis [58]. Evidence shows that psoriasis has multi factor origins, 
with the coexistence of  underlying endogenous factors to its on-
set, in both, for triggering and for exacerbation, like skin trauma 
[46] (physical, pharmacological, electrical, surgical), successive up-
per respiratory tract infections [47], improper bowel, liver func-
tions, inadequate nutrition, metabolic, immune disorders [84] and 
periodontal diseases [6, 43, 44, 48-50, 78, 83].
Emotional distress, is one of  most important risk factor related to 
Psoriasis because affects the disease in many ways. The implica-
tions with periodontal diseases are because often psoriasis patient 
under negative emotional influences living including periods in 
which there is a decrease of  personal care including proper oral 
hygiene [37]. It leads to the oral dysbiosis that made the Psoriasis 
worse [126].
One study compared the prevalence of  periodontitis and alveo-
lar bone loss among individuals with skin forms psoriasis and a 
group of  randomly selected controls showed the prevalence of  
moderate and severe periodontitis was significantly higher among 
psoriasis (24%) when compared to healthy controls (10%). Pso-
riasis had significantly more missing teeth and more areas with 
plaque and bleeding on probing, and 36% of  psoriasis cases had 
one or more sites with radiographic bone loss ≥3 mm, compared 
to 13% of  controls [44]. 
One study with 51 patients recommended that periodontal evalu-
ation is important in psoriatic arthritis [6]. Including there is a 
study about non-plaque-related muco cutaneous disorders related 
to the chronic diseases, a special form of  psoriasis in gums de-
fined as desquamative gingivitis [91].
2.2. Conventional treatments for psoriasis inducing oral out-
comes.
2.2.1. Inducing oral adverse outcomes: Drugs used to treat 
psoriasis conventionally are able to be related to the systemic or 
oral adverse events [13, 14]. No reports about use of  topical treat-
ments for psoriasis inducing oral adverse events. There are re-
ports about the use of  systemic drugs e.g. retinoids, cyclosporine, 
vitamin D, and acitretine that are able to produce oral adverse 
events of  light-to-mild severity, e.g., cheilitis, blisters, xerostomia, 
dental calculus, gingival hyperplasia, concussions, teeth loss or im-
plants loss [4, 15-20]. 
There is a report of  mild to severe primary adverse events, re-
lated anti-EGFR-induced mucositis, BRAF-inhibitor-associated 
hyperkeratosis, osteonecrosis of  the jaw observed, (G.T.) (S.A.M.) 
induced by angiogenesis inhibitors, and other oral lesions of  pso-
riasis specifically linked with imatinib [75]. Report about mucositis 
due the use of  other antineoplastic drugs (e.g. methotrexate)16 
and other substances as bevacizumab [14, 76], but its impact on 
observed outcomes, and repercussions about costs or quality of  
life on psoriasis are still unclear [17, 18, 20, 75, 77].
2.2.2. Worsening oral adverse outcomes: There is reports 
about IgA deficiency and opportunistic infections such as herpes 
labialis, oral candidiasis, folliculitis induced anti-TNF-α treatment 
in a psoriatic arthritis patient. It also was observed previous lo-
cal risk factors, such as (G.T.), (S.A.M.), (F.T.) and oral dysbiosis 
overlapped for observed outcomes [79-81]. In a time line, there 
are reports about (G.T. and S.A.M.) were induced by anti-cancer 
therapies when the drugs were used for the treatment of  psoriasis 
systemic [75, 76]. 
2.2.3. Inducing oral favorable outcomes: There is a case report 
about a 7-year-old female patient with generalized pustular psoria-
sis associated with (G.T.) and anti psoriatic therapy with etretinate 
that caused a remarkable regression in the tongue lesions [75], 
suggesting the (G.T.) is a typical symptom of  psoriasis pustulosa 
generalisata [75].
2.3. Conventional treatments for diseases related to the pso-
riasis inducing adverse oral outcomes: 
The scope is not to assess the impact of  medications in Dentistry 
but is relevant to consider the dental issues for drugs used in man-
agement of  diseases related to the psoriasis, due the potential risk 
factors can stratify, resulting in adverse outcomes.
In a temporal perspective, it is possible to assess diseases related 
to psoriasis and its treatments, such as previous, simultaneous and 
subsequent clinical events to the appearance of  skin lesions [17, 
28].
2.3.1. For Prior Morbidities related to the psoriasis: There 
are many clinical conditions able to promotes Psoriasis, such 
hormonal changes [29], chronic inflammation [30] ,respiratory-
tract infections [31], intense emotional distress [32, 37], meta-
bolic syndrome [26, 33], hypertension [34], circulatory diseases 
[35], recurrent skin infections [17] and mucous diseases [36] and 
their treatments are among the triggers to the diseases that could 
be consider prior morbidities in psoriasis [38] because often are 
overlap with it. Many of  these diseases require drugs (e.g. antico-
agulants) that are able to produce oral cavity impairment [112] as 
bleeding. Also drugs used for management chronic illness also 
can overlap with dental procedures [22] and lead to oral adverse 
outcomes. Some times these events produce distress in many as-
pects able enough to result in a new case of  Psoriasis as primary 
outcome [3, 24, 25].
2.3.2. For Co morbidities related to the psoriasis: Different 
uncontrolled clinical conditions can lead to psoriasis, with simul-
taneous occurrence of  the skin lesions [17]. Once the skin lesions, 
the more out of  control are listed above clinical conditions, the 
greater the chances of  occurrence of  overlap syndrome. Among 
the more prevalent comorbidities, gums diseases [28] is one more 
prevalent and are also related with motivational level concerning 
self-care patient [126]. An important aspect is regarding mental 
health issues of  psoriasis [32], There are studies related to anxiety 
disorders occurrence simultaneous to skin lesions (e.g. phobias, 
panic, generalized anxiety, post-traumatic stress, acute anxiety, at-
tention-deficit, hyperactivity) [37] and dental anxiety [39] as well. 
Many of  these, often requires drugs for control (e.g., lithium) [27] 
used as co-intervention and able to generate skin unfavorable out-
comes [39]. For the management of  these problems, there are no 
pharmacological resources for psoriasis [37].
2.3.3. For Post Morbidities related to the psoriasis: Reports 
about post-morbidities psoriasis and its treatments demonstrated 
that can produce systemic problems and oral insults. Neural psy-
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chiatric disorders, (e.g. mood disorders) [39] alcoholism can lead 
to damage e.g. hepatitis, cirrhosis, changes in liver function [40] 
and oral lesions as well, e.g. accumulation of  dental plaque, oral 
dysbiosis and coated tongue, that lead to dental decay, periodontal 
diseases and tooth loss [33, 36]. The treatments for these diseases 
usually require many drugs, which can overlap and worsen oral 
health status, and aggravating psoriasis and even reducing life ex-
pectancy [2, 4, 24, 27, 33, 36].
For instance, the administration and discontinuation of  systemic 
corticosteroids may result in worsen of  the skin condition, even 
lead to the development of  a severe form of  psoriasis e.g. gener-
alized pustular psoriasis which can also be triggered by hypocal-
cemia, which also affects mouth [17]. Anticonvulsants that affect 
oral health and can worsen psoriasis [113].
2.4. Dental treatments and psoriasis:
2.4.1.Inducing systemic favourable outcomes to the psoria-
sis: There are reports about improvement in skin forms of  pso-
riasis after adequate dental treatments [22, 46, 80, 126](Table 3).
2.4.2.Triggering the systemic psoriasis: There is oral dysfunc-
tional interaction between psoriasis and some dental treatments 
or some substances for dental use [36]. There is a case report 
specific about dental infection as trigger factor in palmo-plantar 
psoriasis [5]. It is known that many products used in dentistry, 
have the composition, chemicals that can lead to frames contact 
stomatitis, after use, even in people without skin diseases, which 
already can be considered as an additional risk factor, like acrylic 
restorations can worsen psoriasis [42]. 
2.4.3.Worsening the psoriasis: There are additional reports 
about important adverse events relating the worsening of  psoria-
sis to local and systemic adverse outcomes such as dermatologic 
exacerbation after stressful dental procedures e.g. endodontics 
procedures, dental implant placement, or failures in dental care 
planning, that can act as a ‘trigger’ in psoriasis patients or about 
worsening outcomes e.g. some acrylic dental restorations [28, 43]. 
The level of  evidence for oral implant therapy in patients with 
systemic conditions is very low [127].
2.5. Other oral risk factors able to induce exacerbation to the 
psoriasis: There are many clinical conditions with the possibility 
Table 3. Assessment Included Studies Characteristics.
Study N Design Oral disease Life Style Outcome Higgins Domains Tools
Preus 2010 155 Psoriasis / 155 Control Case-control
Alveolar bone loss on 
bite-wing x rays Not cited
Psoriatic patients had more 
bone loss and loss of  teeth 
compared to controls
High
level bias
Rahul et al., 2011
100 patients, 
50 with CP 
and 50 with 
psoriasis
Cross-sec-
tional
Probing pocket 
depth(PPD), clinical at-
tachment loss (CAL)and 
alveolar bone loss 
Not cited
Prevalence of  periodon-
titis is higher in psoriasis 
subjects as compared to 
controls 
High
level bias
Keller JJ et al., 
2012 
115 365 Pso-
riasis /
115 365 
Control
Cohort
Probing pocket depth 
and clinical attachment 
loss
Not cited Increased risk for psoriasis among patients with CPD
High
level bias
Lazidouou 2013 100 Psoriasis / 100 Control Case-control
Probing pocket depth, 
and other indices
Active 
smoking 
status
Periodontitis may be associ-
ated with psoriasis
High
level bias
 Üstün 2013 51 Psoriasis / 51 Control
Case-Con-
trol
Probing pocket depth, 
and other indices Not cited
Periodontitis may be associ-
ated with psoriasis
High
level bias
Nakib S et al., 
2013  
60,457 
women Cohort
Self-reported alveolar 
bone loss, loss of  teeth Not cited
Periodontal bone loss may 
increase risk of  subsequent 
psoriasis
High
level bias
Fadel HT et al., 
2013 
89 psoriasis / 
54 controls Case-control
Probing pocket depth, 
Bleeding on probing 
and alveolar bone level
Not cited
No difference in periodon-
tal profiles, though psoriatic 
pt’s had few teeth remain-
ing.
High
level bias
Skudutyte-Rysstad 
2014
60 patients 
with pso-
riasis and 
120 healthy 
controls
Cross-sec-
tional
Probing pocket 
depth(PPD), clinical at-
tachment los s(CAL)and 
alveolar bone loss
Not cited
Periodontitis more common 
in moderate/ severe psoria-
sis compared to controls
High
level bias
Antal M et al., 
2014
82 psoriasis 
patients and 
89 controls
Case-control
Bleeding on probing, 
clinical attachment level 
and probing depth
Active 
smoking 
status
Risk of  severe periodontal 
disease in psoriasis was six 
times higher in smokers 
than in nonsmokers.
High
level bias
Sharma et al., 
2015 
33 psoriasis 
patients and 
35 healthy 
controls
Case-control
Probing pocket 
depth(PPD), clinical at-
tachment loss (CAL)and 
alveolar bone loss
Not cited
Psoriasis patients had poor 
periodontal status compared 
to controls
High
level bias
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to become oral risk for the universe of  mouth diseases. The scope 
was to assess its impact only on oral issues when related to the 
exacerbations of  psoriasis.
At this scenario, some oral structures e.g. (F.T.), coated tongue 
(C.T.), teeth edges, dental decays can overlap with local environ-
mental factors e.g. oral dysbiosis [36, 53] and produce unfavorable 
outcomes.
(F.T.) also known as scrotal tongue, lingua plicata, plicated tongue 
and furrowed tongue is a benign condition, considered a slight 
variation of  the normal pattern [17], related to genetic inherit-
ance, is one of  most frequent malformation of  the tongue, where 
the deep crypts (fissures) are observed on the dorsum of  the 
tongue. Although these grooves may look unsettling, the condi-
tion is usually painless. Some individuals may complain of  an as-
sociated burning sensation [17, 81]. 
It is a relatively common condition, with a prevalence of  between 
6.8% to 11% found among children [121, 125]. The prevalence of  
the condition increases significantly with age, occurring in 40% 
of  the population after the age of  40 [28]. Thus, (F.T.) appears 
in different clinical conditions, and some syndromes, and it can 
stratify with other risks factors such as dysfunctional nutrition, in-
flammatory processes and mycosis that allows the worsening not 
only psoriasis [36, 51, 68, 69-71], but several other conditions that 
is one of  the most prevalent sign, like in Melkersson-Rosenthal 
syndrome (along with facial nerve paralysis and granulomatous 
cheilitis). It is also seen in most patients with Down syndrome, in 
association with geographic tongue, in patients with oral manifes-
tations of  psoriasis, and in healthy individuals. Fissured tongue is 
also sometimes a feature of  Cowden's syndrome [71].
In some circumstances (F.T.) can overlap with oral dysbiosis re-
sulting in halitosis, and so, it is important to give instructions to 
the patients for mechanical tongue cleansing in the oral hygiene 
routine. Since (F.T.) is entirely benign, no other treatment is in-
dicated and the patient should be reassured that it is a common 
variance of  the normal appearance of  the tongue [81, 114, 117].
(C.T.) coated or white tongue occurs when the surface is colo-
nized by bacteria or fungi, and dead cells become trapped be-
tween the small structures on the tongue surface.
About tongue lesions a study in India with 4926 patients exam-
ined students for two 2 years, and demonstrated that its preva-
lence is about 12.07%, and among the most common lesion di-
agnosed was (C.T.) affecting 28.0% of  the subjects, followed by 
(G.T.) 16.4%, (F.T.) 14.9% and hairy tongue (H.T.)11.5%. Males 
were more frequently affected than females. The most common 
systemic condition observed in the patients with tongue lesions 
was anaemia (189), followed by hypertension (47) and diabetes 
mellitus (38) [93, 96].
A study compared the prevalence of  GT/FT and the correlation 
between tongue lesions and psoriasis severity using the PASI. 348 
psoriasis and 348 healthy controls were selected. According to 
the age of  psoriasis onset, the individuals were classified as hav-
ing early psoriasis and late psoriasis. The severity of  psoriasis was 
determined according to PASI. There is association between pso-
riasis intensity and GT and GT is associated with disease severity 
and may be a marker of  the psoriasis severity [97].
The study of  Dafar et al., [120] identified an association between 
GT and anti-hypertensive medications, as well as the use of  Swed-
ish snus. Non-referred patients with GT (GTgp; n = 130) and FT 
(FTgp; n = 62) were examined by general practitioners (gp) and 
compared to a control group without oral mucosal lesions (C; 
n = 1029). Referred patients with GT (GTs; n = 166) and FT (FTs; 
n = 15) were examined by oral medicine specialists (s) and com-
pared to GTgp and FTgp. Statistical analyses were performed 
using unpaired t-test or Fisher's exact test. A multiple logistic re-
gression model was developed to control for age and gender as 
confounders.
GT group patients used more anti-hypertensive medications and 
Swedish snus (p < 0.01). The GTgp group consisted of  older 
males (p < 0.001) compared to C. Compared to the GTgp group, 
the GTs group was younger, more likely to have symptomatic le-
sions (p < 0.0001) and comprised of  more females. Among the 
groups examined, FT patients had the highest mean age. It also 
found differences in the activities and symptoms of  the lesions 
between referred patients and their counterparts of  controls who 
were seen in general dental practice; these parameters influenced 
the results when these conditions were taken into account.
The study of  Al-Maweri et al., [122] about prevalence of  Oral Mu-
cosa Lesions (OML) in 310 elderly people in Yemen indicated the 
most frequently observed lesions were fissured tongue (34.2%), 
benign tumors (17.1%), hairy tongue (16.5%), and qat-induced 
white lesions (12.6%). Hairy tongue, qat-induced white lesions, 
and shammah keratosis were associated with men (P < 0.01, P < 
0.05, and P < 0.05, respectively), whereas geographic tongue was 
associated with women (P < 0.05). The presence of  one or more 
lesions was significantly associated with low education level (P < 
0.05). Certain OMLs showed a significant association with smok-
ing and qat chewing (P < 0.05). No association was found be-
tween the occurrence of  OMLs and denture wearing (P > 0.05).
The study of  Pavelic et al., [124] to identify genetic changes that 
may be the early hallmarks of  epithelial cell over proliferation, 
was searched for p53 and nm23-H1 allelic deletions in oral benign 
epithelial lesions. In the study group were 25 benign epithelial 
lesions (lichen planus--17; leukoplakia--8; recurrent aphthous ul-
cers--2; one specimen diagnosed as benign migratory glossitis). 
Among 21 samples analysed for exon 4 (p53 gene) LOH, only 
6 were informative, with no loss of  either allele. OF 23 samples 
tested for LOH at intron 6 of  p53 gene, 8 were informative, again 
with no presence of  LOH. For nm23-H1 gene, the analysis was 
performed on a total of  24 cases. Of  them, 16 were informa-
tive, however, none exhibited LOH at this locus. In conclusion, 
whereas the presence of  gross gene alterations (LOH) would have 
been definitive evidence for the involvement of  p53 and/or nm23 
in the hyper proliferation process, the absence of  LOH does not 
exclude the presence of  either smaller mutations, altered regula-
tion of  normal gene, or dysfunction at the level of  wild type pro-
tein. Alternatively, p53 and nm23-H1 may have no relation to oral 
lesion formation, and cannot presently be considered as an early 
step in benign, tissue transformation.
Conclusions
For clinicians, It is important consider oral implications for all 
psoriasis patients. Despite the detailed search performed, among 
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10 selected, no study had high enough methodological standards 
that could permit establishing a cause-effect relationship between 
these variables, but the possibility of  an association between pso-
riasis and oral health is known [56]. It is known that dental dis-
eases can influence the individual’s overall health, but in psoriasis 
its influence can generate complex, intricate, and uncertain out-
comes [48, 50, 57]. 
Even not performing the analysis of  the intrinsic mechanism 
of  the phenomena, it is known that some factors, such as, the 
periodontal disease microbiota may aggravate or predispose to 
systemic diseases [59]. It is known that the lack of  control of  
hygiene can lead into infection of  the respiratory tract, especially 
in patients with some comorbidities, like diabetes which can result 
in cardiovascular diseases (CVD), frequent in psoriasis [19, 24, 49, 
58, 60, 61].
 
Postmortem studies from cardiovascular diseases patients dem-
onstrate the similarity among microbiota dental bio-films from 
periodontal disease and those found in the large arteries of  ather-
osclerotic plaques, inclusive, a clinical condition highly prevalent 
in psoriasis [31, 49, 57, 63].
There are reports about periodontitis and chronic plaque psoria-
sis [3, 28, 44, 47, 64, 65] and other clinical conditions associated, 
including one study related the jaw bone loss in patients with 
moderate to severe psoriasis and periodontal disease is greater 
than the average bone loss in patient clinically similar conditions, 
but without periodontal disease [43, 126]. According the results it 
is important that further studies should enhance the main aspects 
of  methodological quality and randomized clinical trials with 
good quality of  evidence need to be conducted to ensure that this 
scenario is adequately evaluated [125]. For the practice, regarding 
the diagnosis, treatment and control, will give better outcomes 
than we have be seen today [73].
The adoption of  ASA physical status classification system from 
American Society of  Anesthesiologists for assessment clinical 
risks should be adopted by professionals prior any dental inter-
ventions in psoriasis [74, 126] (Table 4) .
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Table 4. American Society of  Anesthesiologists (ASA) Scale.
Scale Characteristics of  individuals or patients
ASA 1 Healthy individuals without systemic disease
ASA 2 Individuals with mild-to-moderate systemic disease
ASA 3 Patients with severe systemic disease, with limited or altered although not disabling activity
ASA 4 Patients with severe systemic disabling disease and constant risk of  death
ASA 5 Patients terminally ill
ASA 6 Patient in a state of  brain death, with potential organ donor
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